Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Strategic Asset Allocation Index
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Strategic Asset Allocation Index of 122.0% as of June 2023. Strategic assets (PP&E of CN¥8.76 Billion plus long-term investments of CN¥-) total CN¥8.76 Billion, measured against net assets of CN¥7.18 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 600866 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Starlake Bioscience Co Inc Zhaoqing Guangdong Strategic Asset Allocation Index (2000–2022)
This chart shows how Starlake Bioscience Co Inc Zhaoqing Guangdong's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 122.0%, representing strategic assets of CN¥8.76 Billion against net assets of CN¥7.18 Billion CNY. For live market cap and overall valuation, see 600866 market cap.
Annual Strategic Asset Allocation Index for Starlake Bioscience Co Inc Zhaoqing Guangdong (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Starlake Bioscience Co Inc Zhaoqing Guangdong from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Starlake Bioscience Co Inc Zhaoqing Guan (600866) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 129.8% | CN¥9.00 Billion | CN¥9.00 Billion | CN¥- | CN¥6.93 Billion | ▲ +57.5 pp |
| 2021 | 72.3% | CN¥1.28 Billion | CN¥1.28 Billion | CN¥- | CN¥1.78 Billion | ▼ -4.1 pp |
| 2020 | 76.4% | CN¥1.28 Billion | CN¥1.28 Billion | CN¥- | CN¥1.67 Billion | ▲ +12.7 pp |
| 2019 | 63.7% | CN¥968.92 Million | CN¥929.92 Million | CN¥38.99 Million | CN¥1.52 Billion | ▼ -21.7 pp |
| 2018 | 85.5% | CN¥817.44 Million | CN¥778.45 Million | CN¥38.99 Million | CN¥956.42 Million | ▼ -4.1 pp |
| 2017 | 89.6% | CN¥819.21 Million | CN¥780.21 Million | CN¥38.99 Million | CN¥914.14 Million | ▲ +13.9 pp |
| 2016 | 75.7% | CN¥812.34 Million | CN¥773.34 Million | CN¥38.99 Million | CN¥1.07 Billion | ▼ -9.3 pp |
| 2015 | 85.1% | CN¥891.90 Million | CN¥852.90 Million | CN¥38.99 Million | CN¥1.05 Billion | ▲ +16.9 pp |
| 2014 | 68.2% | CN¥1.00 Billion | CN¥1.00 Billion | CN¥- | CN¥1.47 Billion | ▼ -25.6 pp |
| 2013 | 93.7% | CN¥1.37 Billion | CN¥1.37 Billion | CN¥- | CN¥1.47 Billion | ▼ -40.4 pp |
| 2012 | 134.1% | CN¥2.19 Billion | CN¥2.19 Billion | CN¥- | CN¥1.63 Billion | ▲ +34.2 pp |
| 2011 | 100.0% | CN¥1.80 Billion | CN¥1.80 Billion | CN¥- | CN¥1.80 Billion | ▲ +56.4 pp |
| 2010 | 43.6% | CN¥701.17 Million | CN¥701.17 Million | CN¥- | CN¥1.61 Billion | ▼ -27.3 pp |
| 2009 | 70.8% | CN¥722.61 Million | CN¥722.61 Million | CN¥- | CN¥1.02 Billion | ▼ -31.0 pp |
| 2008 | 101.8% | CN¥790.69 Million | CN¥790.69 Million | CN¥- | CN¥776.46 Million | ▼ -4.8 pp |
| 2007 | 106.6% | CN¥791.24 Million | CN¥791.24 Million | CN¥- | CN¥742.02 Million | ▲ +11.5 pp |
| 2006 | 95.1% | CN¥848.73 Million | CN¥848.73 Million | CN¥- | CN¥892.18 Million | ▼ -0.5 pp |
| 2005 | 95.7% | CN¥837.00 Million | CN¥837.00 Million | CN¥- | CN¥874.86 Million | ▲ +21.8 pp |
| 2004 | 73.8% | CN¥659.65 Million | CN¥659.65 Million | CN¥- | CN¥893.38 Million | ▲ +25.8 pp |
| 2003 | 48.0% | CN¥434.39 Million | CN¥434.39 Million | CN¥- | CN¥904.58 Million | ▼ -3.3 pp |
| 2002 | 51.3% | CN¥428.29 Million | CN¥428.29 Million | CN¥- | CN¥834.94 Million | ▲ +1.6 pp |
| 2001 | 49.7% | CN¥375.68 Million | CN¥375.68 Million | CN¥- | CN¥755.58 Million | ▲ +3.9 pp |
| 2000 | 45.8% | CN¥344.04 Million | CN¥344.04 Million | CN¥- | CN¥751.40 Million | — |